课题基金 / 基金详情

项目摘要

项目成果

Anjaneyulu Kowluru的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):新出现的证据表明,小g蛋白[如Rac1和Cdc42]参与胰岛细胞中葡萄糖刺激的胰岛素分泌[GSIS]。然而,葡萄糖介导的这些蛋白质激活的精确细胞机制仍然只是部分被理解。使用通用的[例如,他汀类药物]和更特异性的前药[例如,烯丙基或乙烯基法尼醇和香叶香醇]和拟肽[例如,GGTI-2147]蛋白质丙烯基转移酶[PPTases]抑制剂,我们最近报道了胰岛G-蛋白的c端戊烯酰化对于GSIS是必不可少的。我们还获得了初步证据,表明pptase的表达缺陷,以及葡萄糖介导的特定g蛋白在2型糖尿病啮齿动物模型胰岛中的激活。基于这些和其他初步数据,我们假设葡萄糖介导的pptase激活是胰岛GSIS的必要条件,并且葡萄糖缺乏pptase激活导致体外和体内糖毒性和2型糖尿病模型中的GSIS缺陷。我们将利用各种生化、生理学和分子生物学方法在正常大鼠胰岛和INS-1细胞中验证我们的假设。特异性目的1是证明葡萄糖介导的pptase激活对于分离细胞中的GSIS是必要的。我们将确定葡萄糖对分离细胞中pptase的磷酸化状态和相关催化激活的调节。我们将通过转染显性阴性PPTase突变体或通过sirna介导的内源性PPTase耗竭来进一步确定GSIS中PPTase激活的本质。特异性目的2是证明在体外和体内GSIS受损模型中,葡萄糖介导的pptase激活的特异性缺陷以及g蛋白戊烯酰化的相关异常最终导致胰岛素分泌缺陷。首先,我们将研究长期暴露于高血糖条件下的INS-1细胞或正常大鼠胰岛中PPTase信号通路的功能状态、候选g蛋白的戊酰化和随后的GSIS。为了进一步验证我们的假设,我们将把这些体外研究扩展到来自两种2型糖尿病啮齿动物模型的胰岛,即GK大鼠和ZDF大鼠。在此,我们将确定这些动物模型中的GSIS异常是否由于这些胰岛中葡萄糖诱导的pptase激活和特定g蛋白(例如Rac1)的戊烯酰化缺陷。总之,我们认为,拟议的研究是第一个确定体外和体内GSIS受损模型中PPTase信号和GSIS异常的潜在原因与影响。我们的目标是研究导致GSIS的细胞刺激-分泌偶联中蛋白戊烯酰化的生理控制,并确定糖毒性和糖尿病模型中导致GSIS异常的信号级联中的潜在缺陷。
英文摘要
DESCRIPTION (provided by applicant): Emerging evidence implicates small G-proteins [e.g., Rac1 and Cdc42] in glucose-stimulated insulin secretion [GSIS] in the islet ¿ cell. However, the precise cellular mechanisms underlying glucose-mediated activation of these proteins remain only partially understood. Using generic [e.g., statins], and more specific pro-drug [e.g., allyl or vinyl farnesols and geranylgeraniols] and peptidomimetic [e.g., GGTI-2147] inhibitors of protein prenyltransferases [PPTases], we have recently reported that C-terminal prenylation of islet G- proteins is essential for GSIS. We have also obtained preliminary evidence to indicate defective expression of PPTases, as well as glucose-mediated activation of specific G-proteins in islets from rodent models of type 2 diabetes. Based on these and other preliminary data, we hypothesize that glucose-mediated activation of PPTases is necessary for GSIS from the islet and that deficient activation of PPTases by glucose results in defective GSIS in in vitro and in vivo models of glucotoxicity and type 2 diabetes. We will test our hypotheses in normal rat islets and INS-1 cells by utilizing various biochemical, physiological, and molecular biological approaches. Specific Aim 1 is to demonstrate that glucose-mediated activation of PPTases is necessary for GSIS in isolated ¿ cells. We will determine the regulation, by glucose, of the phosphorylation status and associated catalytic activation of PPTases in isolated ¿ cells. We will further determine the essential nature of PPTase activation in GSIS either via transfection of dominant negative PPTase mutants or via siRNA-mediated depletion of endogenous PPTases. Specific Aim 2 is to demonstrate that specific defects in glucose-mediated activation of PPTases, and associated abnormalities in G-protein prenylation culminates in insulin secretory defects in in vitro and in vivo models of impaired GSIS. First, we will examine the functional status of the PPTase signaling pathway, prenylation of candidate G-proteins and subsequent GSIS in INS-1 cells or normal rat islets chronically exposed to hyperglycemic conditions. To further validate our hypothesis, we will extend these in vitro studies to islets derived from two rodent models of type 2 diabetes, namely the GK rat and the ZDF rat. Herein, we will determine if abnormalities in GSIS in these animal models are due to defects in glucose-induced activation of PPTases and prenylation of specific G-proteins [e.g., Rac1] in these islets. Together, we believe that the proposed studies are the first to determine potential cause vs. effect for the abnormalities in PPTase signaling and GSIS in in vitro and in vivo models of impaired GSIS. Our goals are to examine the physiological control of protein prenylation in ¿ cell stimulus-secretion coupling leading to GSIS, and to determine potential defects in this signaling cascade leading to abnormalities in GSIS in models of glucotoxicity and diabetes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
BLRD Research Career Scientist Award Application
  • 批准号:
    10337065
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2020
  • 负责人:
    Anjaneyulu Kowluru
  • 依托单位:
BLRD Research Career Scientist Award Application
  • 批准号:
    10514628
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2020
  • 负责人:
    Anjaneyulu Kowluru
  • 依托单位:
Islet Beta-Cell Dysfunction Under Metabolic Stress
  • 批准号:
    9780698
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2020
  • 负责人:
    Anjaneyulu Kowluru
  • 依托单位:
Islet Beta-Cell Dysfunction Under Metabolic Stress
  • 批准号:
    10553637
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2020
  • 负责人:
    Anjaneyulu Kowluru
  • 依托单位:
海外基金